Webinar Description:
Substantial success has been realized in the treatment of common respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and respiratory allergies. By acquiring a deeper understanding of inflammatory mechanisms, new targets for treating these diseases are becoming available. Consequently, researchers are poised to unlock potential advances in research for unmet medical needs for often lifethreatening respiratory disorders such as cystic fibrosis (CF), idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH), and an infectious diseases such as Respiratory Syncytial Virus (RSV).
This webinar provides an R&D update in the respiratory area and covers the need to increase the performance of clinical trials by using new biomarkers and efficient study designs, based on modeling and simulation exercises and new site management models.
Newsletters
Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.
